Pfizer, BioNTech start testing Omicron vaccine
Pfizer and BioNTech said they started a clinical trial to test a new version of their vaccine specifically designed to target the COVID-19 Omicron variant.
Subscribe to:
Post Comments (Atom)
Comments
Post a Comment
Leave a comment. Thanks!
Comentarios de Facebook